Stifel Financial Corp Ultragenyx Pharmaceutical Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 20,961 shares of RARE stock, worth $900,065. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,961

Previous 21,827 3.97%

Holding current value

$900,065

Previous $897,000 29.77%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.21 - $59.36 $34,821 - $51,405	-866 Reduced 3.97%	20,961 $1.16 Million
Q2 2024 Aug 13, 2024	BUY	$37.42 - $51.61 $316,610 - $436,672	8,461 Added 63.3%	21,827 $897,000
Q1 2024 May 13, 2024	BUY	$43.02 - $53.69 $37,513 - $46,817	872 Added 6.98%	13,366 $624,000
Q4 2023 Feb 12, 2024	BUY	$31.73 - $49.19 $84,211 - $130,550	2,654 Added 26.97%	12,494 $597,000
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $151,657 - $202,644	4,343 Added 79.01%	9,840 $350,000
Q2 2023 Aug 14, 2023	BUY	$37.35 - $52.15 $205,312 - $286,668	5,497 New	5,497 $253,000
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $1,694 - $3,159	37 Added 0.96%	3,905 $233,000
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $37,942 - $51,484	610 Added 18.72%	3,868 $281,000
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $7,370 - $8,786	-100 Reduced 2.98%	3,258 $274,000
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $25,791 - $33,894	331 Added 10.93%	3,358 $303,000
Q2 2021 Aug 13, 2021	SELL	$92.19 - $115.71 $54,299 - $68,153	-589 Reduced 16.29%	3,027 $289,000
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $13,362 - $20,966	-125 Reduced 3.34%	3,616 $412,000
Q4 2020 Feb 12, 2021	BUY	$84.4 - $177.39 $59,080 - $124,172	700 Added 23.02%	3,741 $518,000
Q3 2020 Nov 16, 2020	SELL	$72.98 - $90.0 $14,158 - $17,460	-194 Reduced 6.0%	3,041 $250,000
Q2 2020 Aug 14, 2020	SELL	$46.91 - $78.22 $72,710 - $121,241	-1,550 Reduced 32.39%	3,235 $253,000
Q1 2020 May 14, 2020	BUY	$33.8 - $62.9 $161,733 - $300,976	4,785 New	4,785 $213,000
Q2 2019 Aug 14, 2019	SELL	$54.93 - $74.36 $622,192 - $842,275	-11,327 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$39.87 - $69.36 $451,607 - $785,640	11,327 New	11,327 $786,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.6M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Ultragenyx Pharmaceutical Inc. Transaction History